tradingkey.logo
tradingkey.logo
검색

Pacific Biosciences of California Inc

PACB
관심 목록에 추가
1.680USD
-0.060-3.45%
종가 07/02, 13:00ET시세는 15분 지연됩니다
507.29M시가총액
손실P/E TTM

Pacific Biosciences of California Inc

1.680
-0.060-3.45%

자세한 내용은 Pacific Biosciences of California Inc 회사

Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.

Pacific Biosciences of California Inc 정보

종목 코드 PACB
회사 이름Pacific Biosciences of California Inc
상장일Oct 27, 2010
CEOHenry (Christian O)
직원 수575
유형Ordinary Share
회계 연도 종료Oct 27
주소1305 O'brien Drive
도시MENLO PARK
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호94025
전화16505218000
웹사이트https://www.pacb.com/
종목 코드 PACB
상장일Oct 27, 2010
CEOHenry (Christian O)

Pacific Biosciences of California Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Christian O. Henry
Mr. Christian O. Henry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.25M
+9.33%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
132.82K
+17.18%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
132.82K
+17.18%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
--
Dr. Lucy Shapiro, Ph.D.
Dr. Lucy Shapiro, Ph.D.
Independent Director
Independent Director
22.82K
--
Mr. Bill Ericson ,J.D.
Mr. Bill Ericson ,J.D.
Independent Director
Independent Director
--
--
Ms. Kathy P. Ordonez
Ms. Kathy P. Ordonez
Independent Director
Independent Director
--
--
Mr. Mark Van Oene
Mr. Mark Van Oene
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Hannah A. Valantine, M.D.
Dr. Hannah A. Valantine, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher M. (Chris) Smith
Mr. Christopher M. (Chris) Smith
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Christian O. Henry
Mr. Christian O. Henry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.25M
+9.33%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
132.82K
+17.18%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
132.82K
+17.18%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
--
Dr. Lucy Shapiro, Ph.D.
Dr. Lucy Shapiro, Ph.D.
Independent Director
Independent Director
22.82K
--
Mr. Bill Ericson ,J.D.
Mr. Bill Ericson ,J.D.
Independent Director
Independent Director
--
--

자주 묻는 질문

Pacific Biosciences of California Inc의 상위 5대 주주는 누구인가요?

Pacific Biosciences of California Inc의 상위 5대 주주는 다음과 같습니다: Mr. Christian O. Henry

Pacific Biosciences of California Inc(PACB)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Pacific Biosciences of California Inc의 주식을 보유한 기관은 총 540곳이며, 이들이 보유한 주식의 총 가치는 약 192.85M로 전체 발행 주식의 62.12%를 차지합니다. 이는 2025Q4 대비 -19483139.00 증가한 수치입니다.

Pacific Biosciences of California Inc의 최대 수익원은 무엇인가요?

2026Q1 기준, Pacific Biosciences of California Inc의 Consumable revenue 부문이 가장 높은 매출을 기록했으며, 금액은 81.94M로 전체 매출의 51.21%를 차지했습니다.